<DOC>
	<DOCNO>NCT00607243</DOCNO>
	<brief_summary>The currently available stock smallpox vaccine would insufficient face incident smallpox attack . Thus , new manufacture method smallpox vaccine urgently need previous manufacture method use calf lymph longer acceptable view current standard . Recently , CJ corporation Republic Korea develop cell-culture derive smallpox vaccine ( CJ-50300 ) manufacture infect MRC-5 cell . The aim clinical trial ass safety , reactogenicity , immunogenicity CJ-50300 .</brief_summary>
	<brief_title>Safety Efficacy CJ-50300 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy Korean male female subject 20 60 year age time screen visit 2 . Willing participate sign informed consent form 3 . In good general health , without clinically skin disease history , physical examination laboratory test result 4 . Hematocrit &gt; 33 % woman ; &gt; 38 % men 5 . White cell count 3,30012,000/mm3 6 . Total lymphocyte count &gt; 800 cells/mm3 7 . Subjects never vaccinate smallpox vaccine 1 . Diseases condition cause immunodeficiency ( For example ; HIV AIDS , leukemia , lymphoma , generalized malignancy , agammaglobulinemia , history transplantation , therapy alkylating agent , antimetabolite , radiation , oral parenteral corticosteroid ) . 2 . In close physical contact ( household work ) individual disease condition cause immunodeficiency 3 . History present eczema atopic dermatitis 4 . Allergy sensitivity know component vaccine medicine 5 . In close physical contact ( household work ) individual acute chronic skin condition dermatitis , exfoliative dermatitis 6 . Subjects require steroid therapy 7 . Subjects take immunosuppressive therapy 8 . Subjects plan blood donation 9 . Autoimmune disease lupus erythematosus 10 . Subjects work medical institution 11 . Household contact woman pregnant breastfeed 12 . Female subject pregnant breastfeed positive result serum pregnancy test urine pregnancy test , use approve contraceptive sterilization , contraceptive ring injectable , combined oral contraceptive pill barrier contraceptive , combine hormonebased therapy , contraceptive cream , contraceptive jelly , diaphragm condom 13 . Subjects household member &lt; 1 year old work child &lt; 1 year old 14 . Subjects know history Cardiac disease three follow risk factor : hyperpiesia , obesity , hyperlipidemia , glucosuria , sclerosis , cerebral arteriosclerosis 15 . Receipt immunoglobulin steroid within 14 day vaccination 16 . Receipt investigational research agent within 120 day vaccination 17 . HBsAg seropositive 18 . HCV antibody seropositive 19 . HIV seropositive 20 . Subjects fever ( oral temperature &gt; 38â„ƒ ) severe nutrition disorder 21 . Blood donation within 12 week advance screen visit 22 . Subject suitable participate study accord investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Smallpox vaccine efficacy</keyword>
</DOC>